Personalis (PSNL) Projected to Post Earnings on Wednesday

Personalis (NASDAQ:PSNL) is expected to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect Personalis to post earnings of ($0.25) per share and revenue of $15.48 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Personalis Stock Up 9.6 %

Shares of NASDAQ:PSNL opened at $6.04 on Wednesday. Personalis has a 12 month low of $1.13 and a 12 month high of $7.20. The company’s 50-day moving average price is $5.31 and its two-hundred day moving average price is $4.98. The firm has a market cap of $426.73 million, a P/E ratio of -3.60 and a beta of 1.73.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PSNL. Lake Street Capital increased their price objective on shares of Personalis from $7.00 to $9.00 and gave the stock a “buy” rating in a report on Wednesday, January 8th. Needham & Company LLC reissued a “buy” rating and set a $7.25 price objective on shares of Personalis in a report on Wednesday, January 8th. Finally, HC Wainwright cut their target price on shares of Personalis from $11.00 to $8.00 and set a “buy” rating on the stock in a research report on Monday, January 27th.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.